Your browser doesn't support javascript.
Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19.
Ison, Michael G; Scheetz, Marc H.
  • Ison MG; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL USA. Electronic address: mgison@northwestern.edu.
  • Scheetz MH; Midwestern University, Colleges of Pharmacy and Graduate Studies, Departments of Pharmacy and Pharmacology, Pharmacometrics Center of Excellence, Downers Grove, IL USA; Northwestern Memorial Hospital, Chicago, IL, USA.
EBioMedicine ; 63: 103204, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1014451

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Influenza, Human / Amides / COVID-19 Drug Treatment Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Influenza, Human / Amides / COVID-19 Drug Treatment Limits: Humans Language: English Journal: EBioMedicine Year: 2021 Document Type: Article